211 related articles for article (PubMed ID: 32732300)
1. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
[TBL] [Abstract][Full Text] [Related]
2. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
3. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC
Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494
[TBL] [Abstract][Full Text] [Related]
4. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
[TBL] [Abstract][Full Text] [Related]
5. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
[TBL] [Abstract][Full Text] [Related]
7. What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study.
Legdeur N; Badissi M; Yaqub M; Beker N; Sudre CH; Ten Kate M; Gordon MF; Novak G; Barkhof F; van Berckel BNM; Holstege H; Muller M; Scheltens P; Maier AB; Visser PJ
J Gerontol B Psychol Sci Soc Sci; 2021 Sep; 76(8):1499-1511. PubMed ID: 32898275
[TBL] [Abstract][Full Text] [Related]
8. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ
Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040
[TBL] [Abstract][Full Text] [Related]
9. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
10. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
[TBL] [Abstract][Full Text] [Related]
11. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.
Kim JW; Byun MS; Yi D; Lee JH; Ko K; Jeon SY; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
PLoS Med; 2020 Feb; 17(2):e1003022. PubMed ID: 32097439
[TBL] [Abstract][Full Text] [Related]
12. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
Racine AM; Koscik RL; Berman SE; Nicholas CR; Clark LR; Okonkwo OC; Rowley HA; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Gleason CE; Carlsson CM; Johnson SC
Brain; 2016 Aug; 139(Pt 8):2261-74. PubMed ID: 27324877
[TBL] [Abstract][Full Text] [Related]
13. Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adults.
Schreiner SJ; Kirchner T; Narkhede A; Wyss M; Van Bergen JMG; Steininger SC; Gietl A; Leh SE; Treyer V; Buck A; Pruessmann KP; Nitsch RM; Hock C; Henning A; Brickman AM; Unschuld PG
Neurobiol Aging; 2018 Mar; 63():152-161. PubMed ID: 29310864
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
15. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
16. β-Amyloid affects frontal and posterior brain networks in normal aging.
Oh H; Mormino EC; Madison C; Hayenga A; Smiljic A; Jagust WJ
Neuroimage; 2011 Feb; 54(3):1887-95. PubMed ID: 20965254
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
18. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.
DeCarli C; Villeneuve S; Maillard P; Harvey D; Singh B; Carmichael O; Fletcher E; Olichney J; Farias S; Jagust W; Reed B; Mungas D
J Alzheimers Dis; 2019; 68(1):187-196. PubMed ID: 30775991
[TBL] [Abstract][Full Text] [Related]
19. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
Edwards L; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Walker KS; Brenner EK; Nation DA; Maillard P; Bondi MW; Bangen KJ;
J Alzheimers Dis; 2023; 94(2):695-707. PubMed ID: 37302031
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
